These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 203281)

  • 41. Diabetes decreases liver and kidney nuclear 3,5,3'-triiodothyronine receptors in rats.
    Jolin T
    Endocrinology; 1987 May; 120(5):2144-51. PubMed ID: 3552632
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alterations in hepatic nuclear binding of triiodothyronine in experimental diabetes mellitus in rats.
    Wiersinga WM; Frank HJ; Chopra IJ; Solomon DH
    Acta Endocrinol (Copenh); 1982 Jan; 99(1):79-85. PubMed ID: 6277125
    [No Abstract]   [Full Text] [Related]  

  • 43. Fasting decreases triiodothyronine receptor capacity.
    Schussler GC; Orlando J
    Science; 1978 Feb; 199(4329):686-8. PubMed ID: 204004
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thyroid hormone receptors from liver nuclei: characteristics of receptor from normal, thyroidectomized, and triiodothyronine-treated rats; measurement of occupied and unoccupied receptors, and chromatin binding of receptors.
    Bernal J; Coleoni AH; DeGroot LJ
    Endocrinology; 1978 Aug; 103(2):403-13. PubMed ID: 217646
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Uremia decreases nuclear 3,5,3'-triiodothyronine receptors in rats.
    Thompson P; Burman KD; Lukes YG; McNeil JS; Jackson BD; Latham KR; Wartofsky L
    Endocrinology; 1980 Oct; 107(4):1081-4. PubMed ID: 6250792
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reduction in hepatic triiodothyronine binding capacity induced by fasting.
    Burman KD; Lukes Y; Wright FD; Wartofsky L
    Endocrinology; 1977 Oct; 101(4):1331-4. PubMed ID: 198201
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of malic enzyme induction by triiodothyronine in the diabetic rat: reversal by fructose feeding.
    Kaiser FE; Mariash CN; Schwartz HL; Oppenheimer JH
    Metabolism; 1980 Aug; 29(8):767-72. PubMed ID: 6995793
    [No Abstract]   [Full Text] [Related]  

  • 48. Changes in immunoreactive malic enzyme in liver and brown adipose tissue during development of the rat.
    Barton CH; Bailey E
    J Dev Physiol; 1987 Jun; 9(3):215-24. PubMed ID: 3611638
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relationship between dose, mode of administration and effects of triiodothyronine on two hepatic responsive enzymes.
    Lanni A; Cimmino M; Moreno M; Delli Gatti A; Ginestra A; Goglia F
    Horm Metab Res; 1995 Jul; 27(7):314-7. PubMed ID: 7590613
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Nuclear receptors for triiodothyronine. I. Binding of triiodothyronine (T-3) in rat liver following in vivo administration of labelled hormone].
    Kubica A; Nauman A; Witkowska E; Nauman J
    Endokrynol Pol; 1977; 28(3):207-14. PubMed ID: 195802
    [No Abstract]   [Full Text] [Related]  

  • 51. Effect of divalent cations on the binding of 3,5,3'-triiodothyronine to isolated rat liver nuclei.
    Rodriguez-Peña A; Bernal J
    Endocrinology; 1982 Jan; 110(1):246-53. PubMed ID: 6274620
    [No Abstract]   [Full Text] [Related]  

  • 52. Nuclear triiodothyronine receptors in rat brain during maturation.
    Dozin-van Roye B; de Nayer P
    Brain Res; 1979 Nov; 177(3):551-4. PubMed ID: 227542
    [No Abstract]   [Full Text] [Related]  

  • 53. Reciprocal relationship between the levels of the hepatic nuclear binding sites for T3 and DNA replication in the liver of the rat: a possible unifying concept.
    Truitte D; McDermott P; Short J; Desser-Wiest L
    Cytobios; 1983; 38(149):7-19. PubMed ID: 6313301
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relationship between the accumulation of pituitary growth hormone and nuclear occupancy by triiodothyronine in the rat.
    Coulombe P; Schwartz HL; Oppenheimer JH
    J Clin Invest; 1978 Nov; 62(5):1020-8. PubMed ID: 213445
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 5,5'-Diphenylhydantoin decreases specific 3,5,3'-triiodothyronine (T3) binding by rat hepatic nuclear T3 receptors.
    Mann DN; Surks MI
    Endocrinology; 1983 May; 112(5):1723-31. PubMed ID: 6299706
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Triiodothyronine (T3) receptors in brain and liver during induced hypothyroidism in rats [proceedings].
    Dozin-Van Roye B; De Nayer P
    Arch Int Physiol Biochim; 1979 Feb; 87(1):172-3. PubMed ID: 92254
    [No Abstract]   [Full Text] [Related]  

  • 57. Glucagon administration decreases hepatic nuclear triiodothyronine binding capacity.
    Dillmann WH; Bonner RA; Oppenheimer JH
    Endocrinology; 1978 May; 102(5):1633-6. PubMed ID: 217631
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Decreased hepatic nuclear L-triiodothyronine receptors in rats and mice bearing transplantable neoplasms.
    Surks MI; Grajower MM; Tai M; DeFesi CR
    Endocrinology; 1978 Dec; 103(6):2234-9. PubMed ID: 218807
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identical pattern of release of specific triiodothyronine receptors by micrococcal nuclease from rat cerebral cortex and liver nuclei.
    Silva JE
    Endocrinology; 1983 Aug; 113(2):699-705. PubMed ID: 6307648
    [No Abstract]   [Full Text] [Related]  

  • 60. In vivo demonstration of the presence of specific saturable binding sites for triiodothyronine in nuclei of tadpole liver.
    Toth E; Tabachnick M
    Gen Comp Endocrinol; 1979 Jul; 38(3):345-55. PubMed ID: 226454
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.